about
Nitric oxide and peroxynitrite in health and diseaseEffects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the ratInflammation after Ischemic Stroke: The Role of Leukocytes and Glial CellsExtended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic strokeNeuroinflammation and cerebrovascular disease in old age: a translational medicine perspectiveInterleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaBInhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the ratEffects of aliskiren on stroke in rats expressing human renin and angiotensinogen genesBeta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammationMucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injuryThe spleen contributes to stroke-induced neurodegeneration.Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.Vascular endothelial growth factor signaling in hypoxia and inflammation.Neuroprotective effects of consuming bovine colostrum after focal brain ischemia/reperfusion injury in rat modelThe beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injuryThe Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.Effects of repeated restraint stress on platelet endothelial cell adhesion molecule-1 immunoreactivity and protein levels in the gerbil hippocampus after transient cerebral ischemiaAngiotensin II potentiates zinc-induced cortical neuronal death by acting on angiotensin II type 2 receptorImmunomodulatory effect of Hawthorn extract in an experimental stroke model.Inflammatory response and neuronal necrosis in rats with cerebral ischemiaImmunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.The role of microglia and myeloid immune cells in acute cerebral ischemia.The therapeutic potential of the cannabinoids in neuroprotection.The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion.The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1qThe peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.Effect of Cyperus rotundus on ischemia-induced brain damage and memory dysfunction in rats.Human cellular inflammation in the pathology of acute cerebral ischaemiaSignificance of decreased serum interleukin-10 levels in the progression of cerebral infarction.Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.Stroke in the female: role of biological sex and estrogen.Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection.Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage.
P2860
Q24645400-7D45AAF1-0017-41D7-9C8C-EE37736D10F9Q24796019-17C6A3B4-DAE2-485F-984F-02D787093700Q28072250-5D5BF386-BFD7-4E51-A753-69A03650C3ACQ28270066-C3980405-9221-4F7E-84AC-0090F2FE338DQ28393202-4C0DB0EA-68A2-4D93-834A-A6470621C7A7Q28576965-B5BE6B68-9995-41C2-AEEA-9F853B08CAF9Q28583944-E590A4C9-23F5-425A-876D-0AC03D4CDF54Q28744563-5A197867-3DC9-4764-BF6D-59A9B277D392Q30803369-D6909496-DAF0-4A00-9CA5-99E0B78EBE63Q33195470-1C94073C-6D9A-45E9-8626-BD6D382581C5Q33326528-5531330F-1C65-4E98-B9D6-B7B8BAF09F98Q33566724-FD76996D-BD1F-4EBC-A5CD-43C1E7C903E8Q33697097-B99FA803-F138-4A4E-9B63-32F0E523F1A4Q33721685-5C2ED458-7BCC-4A45-AFBA-9BC4465A41E2Q33955612-F7BC59A2-0BFC-4B04-8EE8-60636949712CQ34003451-3CA72C33-8675-48DA-8E9A-14D9C2ECF2F0Q34237954-1D19D7A0-D0FD-4C22-97B9-4ADC68B2C5E1Q34306394-C9CCA6C6-CD7D-4EBC-B93A-6D6AB1A72C60Q34389401-58137D91-E391-4A0F-973A-5F044F039569Q34461965-5650DC8A-1475-460B-8F4F-20CB2F904EA1Q34499816-F46BD616-0CC1-45EB-891B-96913E7FF280Q34546185-809B0961-547D-4A45-B4AA-5F2F3878DAC3Q34578952-FDAF6B1F-3224-467F-A4D3-C39E030D91E7Q34954361-66E16F66-BD76-4054-AF06-09E61692F7FFQ34974856-09726C58-F736-4F7E-8030-CA8925426C76Q35076749-7146D262-753F-4FC6-838A-9B503F96D7CFQ35098041-E7FACFDD-DCC4-41C0-B8BB-490DF62885CDQ35128868-E80D5614-1470-44CF-BA85-77D6FDB7D12FQ35146962-D7C946C9-3F89-4FB0-80BC-265D40DB0410Q35154467-BC348C64-F3B4-4347-8D75-4091F6D73CC0Q35185434-DE571B58-E2FA-4773-8F5C-A8EE6458679BQ35197816-E44ADD24-C642-41A0-85B3-2F19D258068AQ35583807-5FCADB40-C4C2-49F1-9B70-1931049C23F4Q35595895-C541D2A9-3DA8-42BE-B6E8-269FBB9F85E5Q35600801-69858EFC-0014-483A-9348-C45E12CE9751Q35757557-3DEF8C12-FD0A-4FCF-96FC-849F8DAD2E14Q35865533-3BED90E5-76D5-4CD5-AD63-E25B425E7640Q36007453-F3004B4F-2EE2-4769-AF29-91FD4206BF12Q36077396-E66F85EA-2538-4A96-BB32-19F0168E0BF8Q36089101-5524D25A-DB9E-4827-808F-7BE006664B6A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cerebral ischemia and inflammation.
@ast
Cerebral ischemia and inflammation.
@en
Cerebral ischemia and inflammation.
@nl
type
label
Cerebral ischemia and inflammation.
@ast
Cerebral ischemia and inflammation.
@en
Cerebral ischemia and inflammation.
@nl
prefLabel
Cerebral ischemia and inflammation.
@ast
Cerebral ischemia and inflammation.
@en
Cerebral ischemia and inflammation.
@nl
P1476
Cerebral ischemia and inflammation.
@en
P2093
Alexander M
Iadecola C
P356
10.1097/00019052-200102000-00014
P577
2001-02-01T00:00:00Z